A Retrospective Analysis of the Activity and Safety of Oral Etoposide in Heavily Pretreated Metastatic Breast Cancer Patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1524-4741|21|3|241-245

ISSN： 1075-122x

Source： THE BREAST JOURNAL, Vol.21, Iss.3, 2015-05, pp. : 241-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Trofosfamide in Elderly and/or Heavily Pretreated Patients with Metastatic Lung Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 4, 2000-09 ,pp. : 341-344

Karger

Access to resources Recommend Favorite

Salvage Chemotherapy with Gemcitabine and Oxaliplatin in Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Phase II Study

By  

Oncology, Vol. 70, Iss. 4, 2006-10 ,pp. : 273-279

Karger

Access to resources Recommend Favorite

Weekly Cisplatin plus Capecitabine in Metastatic Breast Cancer Patients Heavily Pretreated with both Anthracycline and Taxanes

By  

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 408-413

Karger

Access to resources Recommend Favorite

Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 93, Iss. 3, 2017-05 ,pp. : 191-196

Karger

Access to resources Recommend Favorite

Retrospective Analysis of the Safety of Herceptin® Immunotherapy in Metastatic Breast Cancer

By  

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 58-66

Karger

Access to resources Recommend Favorite